-+ 0.00%
-+ 0.00%
-+ 0.00%

12 Health Care Stocks Moving In Monday's After-Market Session

Benzinga·05/04/2026 21:06:30
Listen to the news

Gainers

  • Indaptus Therapeutics (NASDAQ:INDP) stock increased by 18.6% to $2.55 during Monday's after-market session. The company's market cap stands at $4.7 million.
  • China SXT Pharmaceuticals (NASDAQ:SXTC) stock rose 12.19% to $2.3. The market value of their outstanding shares is at $1.9 million.
  • Biodesix (NASDAQ:BDSX) shares increased by 10.2% to $12.42. The market value of their outstanding shares is at $88.6 million. As per the news, the Q1 earnings report came out today.
  • HealthStream (NASDAQ:HSTM) shares rose 9.45% to $23.26. The market value of their outstanding shares is at $607.2 million. As per the news, the Q1 earnings report came out today.
  • Greenland Mines (NASDAQ:GRML) shares increased by 6.25% to $0.51. The market value of their outstanding shares is at $62.5 million.
  • Skye Bioscience (NASDAQ:SKYE) stock moved upwards by 5.74% to $0.92. The company's market cap stands at $28.9 million.

Losers

  • GeneDx Holdings (NASDAQ:WGS) stock fell 44.8% to $37.49 during Monday's after-market session. The market value of their outstanding shares is at $1.9 billion. The company's, Q1 earnings came out today.
  • Sangamo Therapeutics (NASDAQ:SGMO) shares fell 14.7% to $0.15. The company's market cap stands at $50.1 million.
  • Inspire Medical Systems (NYSE:INSP) shares declined by 14.26% to $47.02. The market value of their outstanding shares is at $1.6 billion. As per the press release, Q1 earnings came out today.
  • Ocugen (NASDAQ:OCGN) shares declined by 9.19% to $1.68. The market value of their outstanding shares is at $609.3 million.
  • Lunai Bioworks (NASDAQ:LNAI) shares declined by 8.51% to $0.3. The market value of their outstanding shares is at $11.6 million.
  • Can Fite Biopharma (AMEX:CANF) stock fell 6.63% to $3.1. The company's market cap stands at $6.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.